What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Glioma, Cancer research, Internal medicine, Surgery and Oncology.
His work carried out in the field of Glioma brings together such families of science as Angiogenesis, Bioinformatics, Gene expression profiling, Immunology and Stem cell.
His research in Cancer research intersects with topics in Cancer cell, Cell growth, In vivo and Transfection.
His research integrates issues of Cancer and Clinical trial in his study of Surgery.
His work deals with themes such as Regulation of gene expression and Magnetic resonance imaging, which intersect with Cancer.
Howard A. Fine has researched Oncology in several fields, including Hazard ratio and Brain tumor, Randomized controlled trial, Pathology.
His most cited work include:
- Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. (1788 citations)
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma (1220 citations)
- microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma (623 citations)
What are the main themes of his work throughout his whole career to date?
Howard A. Fine mainly focuses on Glioma, Internal medicine, Oncology, Cancer research and Surgery.
The various areas that he examines in his Glioma study include Odds ratio, Brain tumor, Case-control study, Pathology and Stem cell.
His study looks at the intersection of Internal medicine and topics like Glioblastoma with Bioinformatics.
His Oncology study incorporates themes from Bevacizumab, Chemotherapy, Toxicity, Tumor progression and Radiation therapy.
As part of the same scientific family, Howard A. Fine usually focuses on Cancer research, concentrating on In vivo and intersecting with In vitro.
His Surgery research incorporates themes from Gastroenterology and Hypophosphatemia.
He most often published in these fields:
- Glioma (41.54%)
- Internal medicine (33.85%)
- Oncology (26.15%)
What were the highlights of his more recent work (between 2012-2021)?
- Glioma (41.54%)
- Internal medicine (33.85%)
- Oncology (26.15%)
In recent papers he was focusing on the following fields of study:
Howard A. Fine mainly investigates Glioma, Internal medicine, Oncology, Glioblastoma and Pathology.
Glioma is a subfield of Cancer research that Howard A. Fine investigates.
His Internal medicine research is multidisciplinary, relying on both Magnetic resonance imaging and Surgery.
As a member of one scientific family, Howard A. Fine mostly works in the field of Surgery, focusing on Hypophosphatemia and, on occasion, Gastroenterology.
His Oncology research includes elements of Phases of clinical research, Adverse effect, Retrospective cohort study and Radiation therapy, Temozolomide.
His Radiation therapy course of study focuses on Cancer and MEDLINE.
Between 2012 and 2021, his most popular works were:
- Modeling Patient-Derived Glioblastoma with Cerebral Organoids. (126 citations)
- A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid For Patients With Glioblastoma (98 citations)
- Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date. (87 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Howard A. Fine mainly investigates Glioma, Internal medicine, Glioblastoma, Stem cell and Cancer research.
Howard A. Fine has included themes like Nuclear medicine, Blood volume and Perfusion, Perfusion scanning in his Glioma study.
His work deals with themes such as Surgery and Oncology, which intersect with Internal medicine.
His Surgery study integrates concerns from other disciplines, such as Adverse effect and Hypophosphatemia.
Within one scientific family, Howard A. Fine focuses on topics pertaining to Bioinformatics under Glioblastoma, and may sometimes address concerns connected to Disease and Immunotherapy.
Howard A. Fine has researched Cancer research in several fields, including Cancer stem cell, Chimeric antigen receptor, Antigen and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
